LMGF(002734)2024-10-08 10:56Financial Performance - The company expects a net profit attributable to shareholders of 49 million to 53 million CNY for the first three quarters of 2024, representing a year-on-year increase of 122.76% to 140.95% compared to 21.9964 million CNY in the same period last year[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be 31.67 million to 35.67 million CNY, reflecting a year-on-year growth of 179.67% to 214.99% from 11.3241 million CNY last year[2]. - For Q3 2024, the expected net profit attributable to shareholders is between 17.2638 million and 21.2638 million CNY, a significant increase of 148.58% to 159.83% compared to a loss of 35.5384 million CNY in the same quarter last year[2]. - The net profit attributable to shareholders after deducting non-recurring losses is estimated to be between 3.2912 million and 7.2912 million CNY, improving from a loss of 41.8970 million CNY in the previous year[2]. - The basic earnings per share for the first three quarters of 2024 is expected to be between 0.13 CNY and 0.15 CNY, compared to 0.06 CNY per share last year[2]. Operational Efficiency - The company has implemented a series of measures to reduce costs and increase efficiency, focusing on core business development and resource optimization[4]. - The company is advancing its "biomanufacturing" technology platform to enhance operational efficiency and profitability[4]. Investment and Uncertainties - The management has reported good returns from external investment projects during the reporting period[4]. - There are currently no significant uncertainties that could affect the accuracy of the earnings forecast[5]. - The financial data provided is preliminary and subject to final audit in the upcoming Q3 report[5].